| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | REPL | Common Stock | Options Exercise | $20.2K | +20K | +11.36% | $1.01* | 196K | Jan 14, 2021 | Direct | |
| transaction | REPL | Common Stock | Sale | -$900K | -20K | -10.2% | $45.02 | 176K | Jan 14, 2021 | Direct | F1 |
| transaction | REPL | Common Stock | Options Exercise | $29.6K | +29.3K | +16.63% | $1.01* | 205K | Jan 15, 2021 | Direct | |
| transaction | REPL | Common Stock | Sale | -$1.28M | -29.3K | -14.26% | $43.58 | 176K | Jan 15, 2021 | Direct | F1 |
| transaction | REPL | Common Stock | Options Exercise | $5.78K | +5.73K | +3.25% | $1.01* | 182K | Jan 19, 2021 | Direct | |
| transaction | REPL | Common Stock | Sale | -$25.9K | -600 | -0.33% | $43.24 | 181K | Jan 19, 2021 | Direct | F1, F2 |
| transaction | REPL | Common Stock | Sale | -$217K | -5.13K | -2.83% | $42.38 | 176K | Jan 19, 2021 | Direct | F1, F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | REPL | Employee Stock Option (right to buy) | Options Exercise | $0 | -20K | -15.6% | $0.00 | 108K | Jan 14, 2021 | Common Stock | 20K | $1.01 | Direct | F5 |
| transaction | REPL | Employee Stock Option (right to buy) | Options Exercise | $0 | -29.3K | -27.05% | $0.00 | 78.9K | Jan 15, 2021 | Common Stock | 29.3K | $1.01 | Direct | F5 |
| transaction | REPL | Employee Stock Option (right to buy) | Options Exercise | $0 | -5.73K | -7.26% | $0.00 | 73.2K | Jan 19, 2021 | Common Stock | 5.73K | $1.01 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. |
| F2 | The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.88 to $43.86. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F3 | The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.76. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F4 | Following the sales reported on this Form 4, the reporting person continues to beneficially own 175,994 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 458,852 shares of the Issuer's common stock, 284,936 of which are exercisable as of the date hereof. The original Form 4 filed on January 19, 2021 is being amended by this Form 4 solely to correct an administrative error, which misreported the total number of options held by the reporting person and the amount exercisable as of January 19, 2021. |
| F5 | The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. |